Exploring Smoldering Multiple Sclerosis and BTK Inhibition

Disclosures

DISCLOSURE POLICY
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Continuing Education, CMSC and TFF require that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. CMSC and TFF mitigate all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs.

Furthermore, CMSC and TFF seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC and TFF are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.

FACULTY DISCLOSURES
The faculty reported the following relevant financial relationships with ineligible companies related to the educational content of this CE activity.

Jiwon Oh, MD, PhD, FRCPC, has reported the following relevant financial relationships:
Consulting Fees–Biogen, Bristol Myers Squibb, EMD Serono, Inc., Horizon Therapeutics, Novartis Pharmaceuticals, Roche, Sanofi
Advisory Board–EMD Serono, Inc., Roche, Sanofi
Other (Grant to institution)–Biogen, Roche

Amy Perrin Ross, APN, MSN, CNRN, MSCN, has reported the following relevant financial relationships:
Consulting/Advisor/Speaker Fees–Alexion Pharmaceuticals, Amgen/Horizon, ArgenX, Banner, Bristol Myers Squibb, EMD Serono, Inc., Roche, Sandoz, TG Therapeutics, UCB, Inc., Viatris

All of the relevant financial relationships listed for these individuals have been mitigated.

STAFF DISCLOSURES
Laurie Scudder, DNP, NP, served as a planner and reviewer and has disclosed no relevant financial relationships. All other staff of the CMSC who are in a position to control content have disclosed no relevant financial relationships.

The planners, reviewers, editors, staff, and other members of The France Foundation who are in a position to control content have disclosed no relevant financial relationships.

DISCLOSURE OF UNLABELED USE
CMSC and TFF require faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental and/or investigational (not FDA-approved); and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that are outside of US Food and Drug Administration approved labeling.

This information is intended solely for continuing education and is not intended to promote off-label use of these medications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by an educational grant received from Novartis Pharmaceuticals Corporation.

DISCLAIMER

CMSC and TFF present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC, TFF, and the commercial supporter(s) assume no liability for the information herein.

PRIVACY POLICY

CMSC and TFF protect the privacy of personal and other information regarding participants and educational collaborators. TFF will not release personally identifiable information to a third party without the individual’s consent, except when such information is required for reporting purposes to the ACCME.

CMSC and TFF maintain physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed at https://www.francefoundation.com/privacy.